Metabolic targeting, HDAC inhibitors, and non small cell lung cancer?

被引：0
|
作者：
Gray, S. G. [1 ]
O'Byrne, K. J. [1 ]
Ahmad, S. [1 ]
机构：
[1] St James Hosp, Dept Clin Med, Dublin 8, Ireland
来源：
LUNG CANCER | 2009年 / 63卷
关键词：
D O I：
10.1016/S0169-5002(09)70002-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2
引用
收藏
页码：S1 / S1
页数：1
相关论文
共 50 条
  • [1] HDAC inhibitors as a means to allow for metabolic targeting in non-small cell lung cancer?
    Gray, Steven G.
    Davies, Anthon M.
    O'Byrne, Kenneth J.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S796 - S796
  • [2] HDAC inhibitors: a new radiosensitizer for non-small-cell lung cancer
    Zhu, Lucheng
    Wu, Kan
    Ma, Shenglin
    Zhang, Shirong
    TUMORI, 2015, 101 (03) : 257 - 262
  • [3] Combination of HDAC and topoisomerase inhibitors in small cell lung cancer
    Gray, Jhanelle
    Cubitt, Christopher L.
    Zhang, Shumin
    Chiappori, Alberto
    CANCER BIOLOGY & THERAPY, 2012, 13 (08) : 614 - 622
  • [4] Targeting MET: Discovery of Small Molecule Inhibitors as Non-Small Cell Lung Cancer Therapy
    Wang, Chaofan
    Lu, Xiaoyun
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (12) : 7670 - 7697
  • [5] Targeting metabolic enzyme with locked nucleic acids in non-small cell lung cancer
    Zhang, Wen Cai
    Lim, Bing
    CANCER RESEARCH, 2014, 74 (19)
  • [6] Activity of BTK and HDAC inhibitors alone and in combination in a mouse model of non-small cell lung cancer
    Lobe, Corrinne G.
    Allain, Michael J.
    Yang, Wenyi
    Sirisawad, Mint
    Balasubramanian, Sriram
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [7] Targeting non-small cell lung cancer with small-molecule EGFR tyrosine kinase inhibitors
    Singh, Mahaveer
    Jadhav, Hemant R.
    DRUG DISCOVERY TODAY, 2018, 23 (03) : 745 - 753
  • [8] Targeting EGFR mutants with non-cognate kinase inhibitors in non-small cell lung cancer
    Wang, Bo
    Shen, Wei
    Yang, Hua
    Shen, Jinjie
    Sun, Tianfeng
    MEDICINAL CHEMISTRY RESEARCH, 2014, 23 (10) : 4510 - 4530
  • [9] Targeting EGFR mutants with non-cognate kinase inhibitors in non-small cell lung cancer
    Bo Wang
    Wei Shen
    Hua Yang
    Jinjie Shen
    Tianfeng Sun
    Medicinal Chemistry Research, 2014, 23 : 4510 - 4530
  • [10] Targeting MEK in non-small cell lung cancer
    Lara, Matthew S.
    Blakely, Collin M.
    Riess, Jonathan W.
    CURRENT PROBLEMS IN CANCER, 2024, 49
12345